Waldenstrom's Macroglobulinemia

FDA expands use of Imbruvica to treat rare form of blood cancer
Yahoo/Reuters
Thu, 01/29/15 - 07:19 pm
FDA
Imbruvica
JNJ
Pharmacyclics
blood cancer
Waldenstrom's Macroglobulinemia
Keryx Biopharmaceuticals Announces Positive Phase 2 Study Results Of Perifosine As A Single Agent For The Treatment Of Waldenstrom's Macroglobulinemia
Medical News Today
Sat, 01/30/10 - 12:15 pm
Keryx
Waldenstrom's Macroglobulinemia